Invention Grant
- Patent Title: Activated neurotensin molecules and the uses thereof
-
Application No.: US15111835Application Date: 2015-01-19
-
Publication No.: US09821072B2Publication Date: 2017-11-21
- Inventor: Guillaume Jacquot , Pascaline Lecorche , Michel Khrestchatisky
- Applicant: VECT-HORUS , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Applicant Address: FR Marseille FR Paris
- Assignee: VECT-HORUS,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee: VECT-HORUS,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee Address: FR Marseille FR Paris
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP14305074 20140120
- International Application: PCT/EP2015/050856 WO 20150119
- International Announcement: WO2015/107182 WO 20150723
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K7/06 ; A61K38/10 ; A61K38/08 ; A61P25/08 ; A61P25/00 ; A61P9/00 ; A61K47/48 ; A61K38/00

Abstract:
The present invention relates to activated neurotensin, pharmaceutical compositions comprising the same, and the uses thereof. The compounds and compositions of the invention may be used, e.g., to reduce body temperature, attenuate or halt seizures, reduce excitotoxicity, promote neuroprotection, reduce neuroinflammation and aberrant axonal sprouting or reduce pain.
Public/Granted literature
- US20160354480A1 ACTIVATED NEUROTENSIN MOLECULES AND THE USES THEREOF Public/Granted day:2016-12-08
Information query